Search results for "Teas"

showing 10 items of 619 documents

Kinetics of in vivo inhibition of tissue cathepsin d by pepstatin A

1988

1. 1. We have investigated the kinetics of inhibition of cathepsin D in heart, liver and skeletal muscle of CD-1 mice following administration of 25, 50, 100 and 200 mg/kg i.p. of pepstatin A, a specific inhibitor of this protease. 2. 2. In the liver, a significant inhibition of cathepsin D occurred up to at least 15 days, whereas, in heart and skeletal muscle, this inhibition lasted for a much shorter period of time. 3. 3. These results show that the recovery of enzyme activity to normal values is dose-dependent and that, at the same dose level, marked differences occur in the recovery of enzyme activity in these organ tissues, the liver being the most sensitive one. © 1988.

Pepstatin Amedicine.medical_treatmentPeriod (gene)KineticsCathepsin DBiochemistryCathepsin DMicechemistry.chemical_compoundIn vivoPepstatinsmedicineAnimalsProteasebiologyMusclesMyocardiumSkeletal muscleEnzyme assayKineticsmedicine.anatomical_structureLiverchemistryBiochemistrybiology.proteinFemaleProteinase InhibitorsOligopeptidesPepstatin
researchProduct

Deciphering the Potential of Pre and Pro-Vitamin D of Mushrooms against Mpro and PLpro Proteases of COVID-19: An In Silico Approach

2022

Vitamin D’s role in combating the SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2), the virus causing COVID-19, has been established in unveiling viable inhibitors of COVID-19. The current study investigated the role of pre and pro-vitamin D bioactives from edible mushrooms against Mpro and PLpro proteases of SARS-CoV-2 by computational experiments. The bioactives of mushrooms, specifically ergosterol (provitamin D2), 7-dehydrocholesterol (provitamin-D3), 22,23-dihydroergocalciferol (provitamin-D4), cholecalciferol (vitamin-D3), and ergocalciferol (vitamin D2) were screened against Mpro and PLpro. Molecular docking analyses of the generated bioactive protease complexes unr…

Pharmaceutical Scienceedible mushroomsMolecular Dynamics SimulationViral Nonstructural ProteinsAnalytical Chemistrypro-vitamin-DErgosterolDrug DiscoveryEndopeptidasespre-vitamin-DHumansProtease InhibitorsPhysical and Theoretical ChemistryVitamin DSARS-CoV-2Organic ChemistryProvitaminsin-silico studiesSettore CHIM/08 - Chimica FarmaceuticaCOVID-19 Drug TreatmentMolecular Docking SimulationChemistry (miscellaneous)Molecular MedicineAgaricalesedible mushrooms; SARS-CoV-2; pre-vitamin-D; pro-vitamin-D; in-silico studiesPeptide HydrolasesMolecules; Volume 27; Issue 17; Pages: 5620
researchProduct

Dual effect mediated by protease-activated receptors on the mechanical activity of rat colon

2002

1. The present study examined the mechanical effects of agonist enzymes and receptor-activating peptides for protease-activated receptor (PAR)-1 and PAR-2 on longitudinal and circular muscle of rat isolated colonic segments in the attempt to clarify the PAR functional role in intestinal motility. 2. The responses to PAR-1 and PAR-2 activation were examined in vitro by recording simultaneously the changes of endoluminal pressure (index of circular muscle activity) and of isometric tension (index of longitudinal muscle activity). 3. Both PAR-1 agonists, thrombin (0.1 nM - 3 microM) and SFLLRN-NH2 (1 nM - 3 microM), and PAR-2 agonists, trypsin (0.1 nM - 10 microM) and SLIGRL-NH2 (1 nM - 10 mic…

PharmacologyAgonistmedicine.medical_specialtymedicine.drug_classMotilityBiologyApaminPotassium channelchemistry.chemical_compoundEndocrinologychemistryInternal medicineTetrodotoxinmedicineProtease-activated receptormedicine.symptomReceptorMuscle contractionBritish Journal of Pharmacology
researchProduct

Anti-inflammatory actions of aprotinin provide dose-dependent cardioprotection from reperfusion injury

2008

Background and purpose: Myocardial injury following ischaemia and reperfusion has been attributed to activation and transmigration of polymorphonuclear leukocytes (PMNs) with release of mediators including oxygen-derived radicals and proteases causing damage. Experimental approach: We studied the serine protease inhibitor aprotinin in an in vivo rabbit model of 1 h of myocardial ischaemia followed by 3 h of reperfusion (MI+R). Aprotinin (10 000 Ukg−1) or its vehicle were injected 5 min prior to the start of reperfusion. Key results: Myocardial injury was significantly reduced with aprotinin treatment as indicated by a reduced necrotic area (11±2.7% necrosis as percentage of area at risk aft…

PharmacologyCardioprotectionProteasesNecrosisAntifibrinolyticmedicine.drug_classbusiness.industryIschemiaPharmacologymedicine.diseaseApoptosisImmunologymedicineAprotininmedicine.symptombusinessReperfusion injuryhormones hormone substitutes and hormone antagonistsmedicine.drugBritish Journal of Pharmacology
researchProduct

Aktivität Eiweiss spaltender Enzyme in Fischen

1958

Fresh tissues from sea fishes show much higher activities of cathepsins than the corresponding mammalian tissues. The significance of these findings is discussed. There is no indication for the presence in fresh extracts of fish muscle of either proteinases with a pH optimum near neutrality or of decarboxylases for glutamic and aspartic acids. The activities of glycylglycine dipeptidase in fish muscle are found to be at the upper limit of the values obtained by other workers with mammalian tissues.

PharmacologyCathepsinProteasesPh optimumGlycylglycine dipeptidaseCell BiologyBiologyMolecular biologyCellular and Molecular NeuroscienceBiochemistryPeptide HydrolasesMolecular MedicineFish <Actinopterygii>Molecular BiologyExperientia
researchProduct

Nostotrebin 6 Related Cyclopentenediones and δ-Lactones with Broad Activity Spectrum Isolated from the Cultivation Medium of the Cyanobacterium Nosto…

2020

Cyanobacteria are an interesting source of biologically active natural products, especially chemically diverse and potent protease inhibitors. On our search for inhibitors of the trypanosomal cysteine protease rhodesain, we identified the homodimeric cyclopentenedione (CPD) nostotrebin 6 (1) and new related monomeric, dimeric, and higher oligomeric compounds as the active substances in the medium extract of Nostoc sp. CBT1153. The oligomeric compounds are composed of two core monomeric structures, a trisubstituted CPD or a trisubstituted unsaturated δ-lactone. Nostotrebin 6 thus far has been the only known cyanobacterial CPD. It has been found to be active in a broad variety of assays, indi…

PharmacologyCyanobacteriaNostocProteasebiologyStereochemistrymedicine.medical_treatmenteducationOrganic ChemistryPharmaceutical ScienceBiological activitybiology.organism_classificationCysteine proteaseAnalytical Chemistrychemistry.chemical_compoundMonomerComplementary and alternative medicinechemistryDrug DiscoverymedicineMolecular MedicineMoietyMoleculeJournal of Natural Products
researchProduct

Screening of cyanobacteria extracts for inhibitory activity against the cysteine protease rhodesain of Trypanosoma brucei

2016

PharmacologyCyanobacteriabiologyChemistryOrganic ChemistryPharmaceutical ScienceTrypanosoma bruceibiology.organism_classificationInhibitory postsynaptic potentialCysteine proteaseAnalytical ChemistryComplementary and alternative medicineBiochemistryDrug DiscoveryMolecular MedicinePlanta Medica
researchProduct

Distribution of protease activity in the blastula and early gastrula ofDiscoglossus pictus

1957

E stata determinata l'attivita proteasica nelle differenti regioni della blastula e della gastrula diDiscoglossus pictus. Nella blastula non esiste una differenza di attivita fra meta animale e vegetativa, quando si prenda come riferimento l'azoto citoplasmatico. Nella giovane gastrula il territorio presuntivo della corda e del sistema nervoso mostra una attivita piu elevata della epidermide presuntiva.

PharmacologyEmbryo NonmammalianProteaseHydrolasesmedicine.medical_treatmentGastrulaCell BiologyBlastulaBiologyEmbryo MammalianBlastulaMolecular biologyGastrulationCellular and Molecular NeuroscienceBlastocystEndopeptidasesBotanymedicineAnimalsHumansMolecular MedicineMolecular BiologyPeptide HydrolasesExperientia
researchProduct

Front Cover: Structure‐Activity Relationships of Benzamides and Isoindolines Designed as SARS‐CoV Protease Inhibitors Effective against SARS‐CoV‐2 (2…

2021

PharmacologyFront coverProteaseChemistrymedicine.medical_treatmentSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Organic ChemistryDrug DiscoverymedicineMolecular MedicineGeneral Pharmacology Toxicology and PharmaceuticsBiochemistryVirologyChemMedChem
researchProduct

Adverse cutaneous reactions associated with the newest antiretroviral drugs in patients with human immunodeficiency virus infection.

2008

HIV-infected patients have a higher risk of developing cutaneous reactions than the general population, which has a significant impact on patients' current and future care options. The severity of cutaneous adverse reactions varies greatly, and some may be difficult to manage. HIV-infected patients just at the beginning of antiretroviral treatment can frequently show a wide variety of adverse drug effects such as drug rashes, hyperpigmentation, hair loss, hypersensitivity reactions, injection site reaction, urticarial reaction, erythema multiforme, toxic epidermal necrolysis or Stevens-Johnson syndrome. The early detection and treatment of cutaneous adverse drug reactions, plus identificati…

PharmacologyMicrobiology (medical)Enfuvirtidebusiness.industryAnti-HIV AgentsEtravirineIntegrase inhibitorHIV Infectionsmedicine.diseaseRaltegravirSkin Diseaseschemistry.chemical_compoundInfectious DiseaseschemistryInjection site reactionImmunologymedicineHumansPharmacology (medical)Protease inhibitor (pharmacology)businessTipranavirmedicine.drugMaravirocThe Journal of antimicrobial chemotherapy
researchProduct